Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia
Authors:
Open Access
- 20 November 2020
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 20 (1) , 1-10
Abstract
Background: Non–small-cell lung cancer (NSCLC) has been reported to develop in patients with interstitial pneumonia (IP); however, clinical, radiological, and pathological features remain to be elucidated. Methods: We retrieved the records of 120 consecutive NSCLC patients associated with IP who underwent surgery at Toranomon Hospital between June 2011 and May 2017. We classified the patients into three groups according to NSCLC location using high-resolution computed tomography: group A, within a fibrotic shadow and/or at the interface of a fibrotic shadow and normal lung; group B, within emphysematous tissue and/or at the interface of emphysematous tissue and normal lung; and group C, within normal lung. In 64 patients, programmed death ligand-1 (PD-L1) status was assessed with immunohistostaining. Results: Most of the patients (89; 70%) were classified as group A. This group tended to have squamous cell carcinoma with the usual interstitial pneumonia (UIP). These cancers were located mainly in the lower lobes and seven of the eight postoperative acute exacerbations (pAE) of IP developed in this group. NSCLC in the group B were mainly squamous cell carcinomas located in the upper lobes. No patient with PD-L1 negative was classified into group B. None of the patients in group C showed UIP. and most of the cancers were adenocarcinoma. The frequency of epidermal growth factor receptor mutation-positive NSCLC was the highest in this group. Conclusions: The three groups each showed characteristic features in terms of tumor location, histopathology, PD-L1 expression, and frequency of pAEof IP.Keywords
This publication has 40 references indexed in Scilit:
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and HeartJournal of Thoracic Oncology, 2015
- The Impact of Lung Cancer on Survival of Idiopathic Pulmonary FibrosisChest, 2015
- A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patientsGeneral Thoracic and Cardiovascular Surgery, 2014
- Lung Cancer in Chronic Interstitial Pneumonia: Early Manifestation From Serial CT ObservationsAmerican Journal of Roentgenology, 2012
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Cryptogenic fibrosing alveolitis and lung cancer: the BTS studyThorax, 2009
- Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer TherapyInternal Medicine, 2009
- Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomesThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Cryptogenic fibrosing alveolitis and lung cancer.Thorax, 1980